As an early adopter of combination treatments, the research team was able to provide an early experience regarding the safety and efficacy of combination treatments in advance of clinical trial results.
Read More
This prestigious award highlights Ochsner’s unwavering dedication to fostering an environment of excellence, both as a workplace and in its delivery of exceptional patient care.
As an early adopter of combination treatments, the research team was able to provide an early experience regarding the safety and efficacy of combination treatments in advance of clinical trial results.
The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.
Ochsner’s implementation of CLEAR1 – CLEAR's security identity platform for account creation, account recovery, and access to healthcare information – is already helping patients quickly and safely regain access to their MyOchsner accounts while reducing manual identity checks.